GSK Commits $30 Billion Investment in U.S. Amid Political and Industry Challenges
TL;DR Summary
GSK announced a $30 billion investment in U.S. research, development, and manufacturing over five years, including $1.2 billion for advanced manufacturing and digital tech, amid President Trump's UK visit, reflecting increased U.S. pharma investments.
- UK's GSK announces $30 billion U.S. pharma investment amid Trump state visit CNBC
- GSK plans $30 billion US investment as pharma tariff threat looms Reuters
- GSK pumps $30bn into America after pressure from Trump The Times
- GSK to invest $30 billion in R&D and Manufacturing in the United States over next 5 years GSK
- GSK pledges $30bn US investment as UK's pharma woes deepen BBC
Reading Insights
Total Reads
0
Unique Readers
2
Time Saved
2 min
vs 2 min read
Condensed
91%
359 → 34 words
Want the full story? Read the original article
Read on CNBC